[go: up one dir, main page]

HK1197274A1 - Micro-rna biomarkers for identifying risk of and/or for diagnosing lung tumour and pharmaceutical compositions thereof - Google Patents

Micro-rna biomarkers for identifying risk of and/or for diagnosing lung tumour and pharmaceutical compositions thereof Download PDF

Info

Publication number
HK1197274A1
HK1197274A1 HK14110741.5A HK14110741A HK1197274A1 HK 1197274 A1 HK1197274 A1 HK 1197274A1 HK 14110741 A HK14110741 A HK 14110741A HK 1197274 A1 HK1197274 A1 HK 1197274A1
Authority
HK
Hong Kong
Prior art keywords
micro
pharmaceutical compositions
diagnosing lung
lung tumour
rna biomarkers
Prior art date
Application number
HK14110741.5A
Other languages
English (en)
Chinese (zh)
Inventor
Gabriella Sozzi
Ugo PASTORINO
Mattia BOERI
Original Assignee
Biomirna Holdings Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI2011A000173A external-priority patent/IT1403685B1/it
Priority claimed from ITMI2011A000174A external-priority patent/IT1406866B1/it
Priority claimed from ITMI2011A000172A external-priority patent/IT1406672B1/it
Application filed by Biomirna Holdings Ltd. filed Critical Biomirna Holdings Ltd.
Publication of HK1197274A1 publication Critical patent/HK1197274A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK14110741.5A 2011-02-07 2012-02-07 Micro-rna biomarkers for identifying risk of and/or for diagnosing lung tumour and pharmaceutical compositions thereof HK1197274A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
ITMI2011A000173 2011-02-07
ITMI2011A000173A IT1403685B1 (it) 2011-02-07 2011-02-07 Procedimento ed apparecchiatura per identificare individui a rischio di tumore polmonare e/o per diagnosticare un tumore polmonare, nonche' composizione e metodo per ridurre o eliminare il rischio di tumore polmonare.
ITMI2011A000172 2011-02-07
ITMI2011A000174A IT1406866B1 (it) 2011-02-07 2011-02-07 Procedimento ed apparecchiatura per identificare individui a rischio di tumore polmonare e/o per diagnosticare un tumore polmonare, nonché composizione e metodo per ridurre o eliminare il rischio di tumore polmonare
ITMI2011A000172A IT1406672B1 (it) 2011-02-07 2011-02-07 Procedimento ed apparecchiatura per identificare individui a rischio di tumore polmonare e/o per diagnosticare un tumore polmonare, nonche' composizione e metodo per ridurre o eliminare il rischio di tumore polmonare.
ITMI2011A000174 2011-02-07
US201161522328P 2011-08-11 2011-08-11
US61/522,328 2011-08-11
PCT/IB2012/000567 WO2012107841A2 (fr) 2011-02-07 2012-02-07 Marqueurs biologiques de micro-arn et procédés pour les utiliser

Publications (1)

Publication Number Publication Date
HK1197274A1 true HK1197274A1 (en) 2015-01-09

Family

ID=46062629

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14110741.5A HK1197274A1 (en) 2011-02-07 2012-02-07 Micro-rna biomarkers for identifying risk of and/or for diagnosing lung tumour and pharmaceutical compositions thereof

Country Status (17)

Country Link
US (4) US20120225925A1 (fr)
EP (1) EP2734636B1 (fr)
AU (2) AU2012215105B2 (fr)
BR (1) BR112014003877A2 (fr)
CA (1) CA2844596A1 (fr)
CY (1) CY1121916T1 (fr)
DK (1) DK2734636T3 (fr)
ES (1) ES2742840T3 (fr)
HK (1) HK1197274A1 (fr)
HR (1) HRP20191481T1 (fr)
HU (1) HUE045731T2 (fr)
IL (1) IL230896B (fr)
PL (1) PL2734636T3 (fr)
PT (1) PT2734636T (fr)
RS (1) RS59161B1 (fr)
SM (1) SMT201900474T1 (fr)
WO (1) WO2012107841A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014003877A2 (pt) 2011-02-07 2017-06-13 Biomirna Holdings Ltd biomarcadores de micro-rna e métodos de uso dos mesmos
EP2733219B1 (fr) * 2012-11-16 2017-09-20 Siemens Aktiengesellschaft Marqueurs miRNA de diagnostic pour la maladie d'Alzheimer
US10011873B2 (en) 2012-11-16 2018-07-03 Universitat Des Saarlandes Diagnostic miRNA markers for Parkinson disease
BR112016015595A2 (pt) * 2014-01-05 2017-10-24 Biomirna Holdings Ltd métodos de determinação de câncer de pulmão
WO2015117205A1 (fr) * 2014-02-06 2015-08-13 Immunexpress Pty Ltd Méthode de signature de biomarqueur, et appareil et kits associés
US20170283883A1 (en) * 2014-09-09 2017-10-05 Fondazione Istituto Firc Di Oncologia Molecolare Methods for lung cancer detection
WO2016049429A1 (fr) * 2014-09-26 2016-03-31 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Biomarqueurs de type microarn pour un état de stress post-traumatique et leurs méthodes d'utilisation
WO2016059241A2 (fr) * 2014-10-17 2016-04-21 Biomirna Holdings Ltd. Produits diagnostiques et thérapeutiques pour le cancer du poumon avec mir-660
TWI571514B (zh) * 2015-01-09 2017-02-21 長庚大學 評估罹患大腸直腸癌風險的方法
TWI626314B (zh) * 2015-01-09 2018-06-11 長庚大學 評估罹患大腸直腸癌風險的方法
WO2018187624A1 (fr) * 2017-04-06 2018-10-11 The United States Government As Represented By The Department Of Veterans Affairs Méthodes de détection du cancer du poumon

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2857881A1 (fr) * 2004-11-12 2006-12-28 Asuragen, Inc. Procedes et compositions comprenant des molecules de micro-arn et des molecules d'inhibiteur de micro-arn
WO2007081720A2 (fr) * 2006-01-05 2007-07-19 The Ohio State University Research Foundation Procédés et compositions basés sur des micro-arn et s'appliquant au diagnostic, au pronostic et au traitement du cancer du poumon
CN103642900B (zh) * 2006-01-05 2016-04-13 俄亥俄州立大学研究基金会 用于诊断和治疗实体癌的基于微小rna的方法和组合物
US8207325B2 (en) * 2006-04-03 2012-06-26 Univ. of Copenhagen MicroRNA biomarkers for human breast and lung cancer
WO2009036332A1 (fr) * 2007-09-14 2009-03-19 Asuragen, Inc. Microarn exprimés de manière différentielle dans le cancer du col de l'utérus et leurs utilisations
US20090186015A1 (en) * 2007-10-18 2009-07-23 Latham Gary J Micrornas differentially expressed in lung diseases and uses thereof
AU2008329755A1 (en) * 2007-11-30 2009-06-04 The Ohio State University Research Foundation MicroRNA expression profiling and targeting in peripheral blood in lung cancer
US20110107440A1 (en) * 2008-06-04 2011-05-05 Andor Pivarcsi Skin cancer associated micrornas
CA2753562A1 (fr) * 2009-02-26 2010-09-02 The Ohio State University Research Foundation Microarn chez les non-fumeurs et methodes et matieres apparentees
EP2341145A1 (fr) * 2009-12-30 2011-07-06 febit holding GmbH Empreinte ARNm dans le diagnostic de maladies
EP2354246A1 (fr) * 2010-02-05 2011-08-10 febit holding GmbH ARNm dans le diagnostic du cancer ovarien
CN101804208A (zh) * 2010-02-26 2010-08-18 南京医科大学 miR-451在制备治疗非小细胞肺癌药物的应用
BR112014003877A2 (pt) 2011-02-07 2017-06-13 Biomirna Holdings Ltd biomarcadores de micro-rna e métodos de uso dos mesmos

Also Published As

Publication number Publication date
IL230896A0 (en) 2014-03-31
EP2734636B1 (fr) 2019-05-22
EP2734636A2 (fr) 2014-05-28
HRP20191481T1 (hr) 2019-11-15
US20150045233A1 (en) 2015-02-12
IL230896B (en) 2019-10-31
US20190062843A1 (en) 2019-02-28
AU2012215105A1 (en) 2014-06-05
RS59161B1 (sr) 2019-10-31
WO2012107841A3 (fr) 2013-01-17
ES2742840T3 (es) 2020-02-17
HUE045731T2 (hu) 2020-01-28
US20210130905A1 (en) 2021-05-06
AU2017213457A1 (en) 2017-08-31
US9926603B2 (en) 2018-03-27
US20120225925A1 (en) 2012-09-06
SMT201900474T1 (it) 2019-09-09
AU2017213457B2 (en) 2019-08-29
PL2734636T3 (pl) 2019-10-31
CA2844596A1 (fr) 2012-08-16
BR112014003877A2 (pt) 2017-06-13
WO2012107841A2 (fr) 2012-08-16
PT2734636T (pt) 2019-09-06
DK2734636T3 (da) 2019-08-26
AU2012215105B2 (en) 2017-05-11
CY1121916T1 (el) 2020-10-14

Similar Documents

Publication Publication Date Title
HK1197274A1 (en) Micro-rna biomarkers for identifying risk of and/or for diagnosing lung tumour and pharmaceutical compositions thereof
WO2013107459A3 (fr) Micro-arn pour le diagnostic du cancer du pancréas et/ou le pronostic de patients atteints d'un cancer du pancréas au moyen d'échantillons de sang
WO2010099342A3 (fr) Procédés de détection du cancer du poumon
EP4461824A3 (fr) Kit ou dispositif de détection du cancer du tractus biliaire, et procédé de détection
WO2013033609A3 (fr) Méthodes et compositions pour le traitement et le diagnostic du cancer
HK1202313A1 (en) Methods and compositions for the treatment and diagnosis of bladder cancer
HK1199100A1 (en) Methods and compositions for the treatment and diagnosis of colorectal cancer
WO2013163568A3 (fr) Procédés d'évaluation du statut de cancer du poumon
WO2013188767A8 (fr) Procédé et système pour mesurer la pharmacocinétique de la curcumine en liposome et sa tétrahydrocurcumine métabolite
EP2795839A4 (fr) Système et procédé de mesure et d'amélioration de l'efficacité des campagnes de médias sociaux
HK1212734A1 (zh) 用於检测创伤後应激障碍(ptsd)的标志物和方法
WO2013049152A3 (fr) Procédés pour évaluer le statut du cancer du poumon
GB201201766D0 (en) Method
EP2666019A1 (fr) Méthodes et kits pour la prédiction du risque d'insuffisance respiratoire, d'insuffisance rénale ou de thrombopénie chez un patient septique par mesure de la concentration sanguine d'endocan
AU2012264524A1 (en) System and method for traceability of an instrumentation system
WO2013009146A3 (fr) Marqueur pour le diagnostic d'une rétinopathie diabétique
EP3207374A4 (fr) Procédé et système de détermination de la concentration d'un analyte dans un échantillon de fluide
EP3161165A4 (fr) Procédé permettant de diagnostiquer une forme infraclinique et clinique du rejet aigu par analyse de séries de gènes prédictifs
EP2673093A1 (fr) Procédé et microsystème pour détecter des analytes présents dans des gouttelettes de liquide.
WO2011083461A3 (fr) Méthode de diagnostic et de surveillance de la schizophrénie et des tauopathies
EP3045916A4 (fr) Trousse et méthode de diagnostic, de pronostic ou de surveillance d'une maladie du foie par mesure de la quantité d'ast
WO2013009143A3 (fr) Marqueur pour le diagnostic d'une rétinopathie diabétique
MX2015007494A (es) Metodo para diagnosticar leucodistrofia metacromatica.
WO2015115923A3 (fr) Profil de micro-arn dans le sang en tant que test pour la détection du cancer du poumon
WO2012014190A3 (fr) Compositions et procédés pour le pronostic du mésothéliome